Early identification of type 2 diabetes: Policy should be aligned with health systems strengthening

Diabetes Care

Volumn 34, Issue 1, 2011, Pages 244-246

  Narayan, K M Venkat ^a   Chan, Juliana ^b   Mohan, Viswanathan ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH PROGRAM; LIFESTYLE MODIFICATION; LOWEST INCOME GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; SCREENING; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH POLICY; HUMANS; INDIA; QUESTIONNAIRES; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

EID: 79951713753     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1952     Document Type: Editorial

References (28)

1. International Diabetes Federation. IDF Diabetes Atlas [Internet], 2009. 4th Edition. International Diabetes Federation, Brussels, Belgium. Available from www.diabetesatlas.org. Accessed 28 October 2010
2. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China.NEngl J Med 2010;362:1090-1101
3. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006;73:126-134 (Pubitemid 43928160)
4. Gaede P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH, Pedersen O. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study. Diabetes Care 2008;31:1510-1515
5. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010;33:1872-1894
6. Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002;45:S13-S17 (Pubitemid 34762209)
7. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23:1563-1580
8. Ritchie GE, Kengne AP, Joshi R, Chow C, Neal B, Patel A, Zoungas S. Comparison of near-patient capillary glucose measurement and a risk assessment questionnaire in screening for type 2 diabetes in a high-risk population in rural India. Diabetes Care 2011;34:44-49
9. Narayan KMV. How generally applicable is a simple diabetes detection questionnaire? Nat Clin Pract End Met 2006;2:196-197
10. World Health Organization, International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. World Health Organization. Geneva, Switzerland, 2006; http://www.who.int/diabetes/publications/ Definition%20and%20diagnosis%20of%20diabetes-new.pdf. Accessed 12 October 2010
11. He G, Sentell T, Schillinger D. A new public health tool for risk assessment of abnormal glucose levels. Prev Chronic Dis Mar 2010;7:A34
12. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731 (Pubitemid 36929335)
13. Randerson J. Vaccines for pennies. New Sci 2005;185:42 (Pubitemid 40275028)
14. Schiffman M, Wacholder S. From India to the world-a better way to prevent cervical cancer.NEngl JMed2009;360:1453-1455
15. Nainggolan L. ADDITION: no significant benefit of intensive therapy in diabetes [Internet], 2010. Lipid/Metabolic. Available from http://www.theheart. org/article/1124453.do. Accessed 12 October 2010
16. Eborall HC, Griffin SJ, Prevost AT, Kinmonth A-L, French DP, Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2007;335:486
17. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, Gregg E, Holman RR, Kirkman MS, Stern M, Tuomilehto J, Wareham NJ. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010;375:1365-1374
18. The CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998;280:1757-1763
19. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518-2523
20. Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007;30:2548-2552 (Pubitemid 47547791)
21. Balagopal P, Kamalamma N, Patel TG, Misra R. A community-based diabetes prevention and management education program in a rural village in India. Diabetes Care 2008;31:1097-1104
22. Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-1575
23. Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, Datta M. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India: the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175-1178
24. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297
25. Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010;33:1484-1490
26. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community: the DEPLOY Pilot Study. Am J Prev Med 2008;35:357-363
27. Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, Fogelholm M, Talja M, Uutela A. Type 2 diabetes prevention in the real world: three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care 2009;32:1418-1420
28. Alleyne G, Stuckler D, Alwan A. The hope and the promise of the UN Resolution on non-communicable diseases. Global Health 2010;6:15